new glp 1 retatrutide 🎙️ EPISODE: Retatrutide—The Triple Agonist *Not licensed* Will this replace the current GLP-1 in the market., This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented results in Retatrutide vs Tirzepatide vs Semaglutide

GLP-1 Obesity or being overweight is a significant risk factor for various serious diseases

In a wellness context, many clients choose Glutathione during periods of high stress, travel or increased demand

Compared to the placebo group, the use of selenium supplements was able to significantly reduce the levels of thyroid peroxidase autoantibodies (TPOAb) (SMD: -2.44, 95% CI: -4.19, -0.69) and thyroglobulin autoantibodies (TgAb) (SMD: -2.76, 95% CI: -4.50, -1.02)

Theyve been through large clinicals trials involving tens of thousands of patients, been approved by the FDA and been prescribed for diabetes for more than 20 years